Day One Biopharmaceuticals, Inc. (DAWN)

NASDAQ: DAWN · Real-Time Price · USD

21.20

+8.42 (65.88%)

At close: Mar 6, 2026, 4:00 PM EST

21.16

-0.04 (-0.19%)

After-hours: Mar 6, 2026, 7:58 PM EST

DAWN Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	197.08	124.97	230.78	85.26	284.31
Short-Term Investments	244.04	406.75	135.56	257.01	-
Cash & Short-Term Investments	441.11	531.72	366.35	342.27	284.31
Cash Growth	-17.04%	45.14%	7.03%	20.39%	550.18%
Accounts Receivable	26.74	13.88	-	-	-
Inventory	6.33	3.32	-	-	-
Other Current Assets	10.93	13.41	8.93	5.61	5.06
Total Current Assets	485.1	562.33	375.27	347.87	289.37
Net Property, Plant & Equipment	4.48	4.71	0.56	0.72	0.28
Other Intangible Assets	18.02	15.63	-	-	-
Other Long-Term Assets	0.23	0.12	0.21	0.47	0.17
Total Assets	507.83	582.79	376.05	349.06	289.82
Accounts Payable	3.73	3.26	2.58	0.26	1.74
Accrued Expenses	54.62	68.63	26.52	15.95	6.71
Current Portion of Leases	0.17	0.01	0.41	0.41	0.2
Unearned Revenue	2	1.55	-	-	-
Total Current Liabilities	60.52	73.45	29.51	16.62	8.66
Long-Term Leases	2.62	2.59	-	0.41	0.02
Other Long-Term Liabilities	3.52	3.99	-	-	-
Total Long-Term Liabilities	6.14	6.59	-	0.41	0.02
Total Liabilities	66.67	80.04	29.51	17.02	8.67
Common Stock	0.01	0.01	0.01	0.01	0.01
Additional Paid-in Capital	1,102	1,057	805.11	601.77	408.63
Accumulated Other Comprehensive Income	0.07	0.08	0.01	-0.07	-
Retained Earnings	-661.4	-554.08	-458.59	-269.67	-127.49
Total Common Shareholders' Equity	441.16	502.75	346.54	332.04	281.15
Shareholders' Equity	441.16	502.75	346.54	332.04	281.15
Total Liabilities & Equity	507.83	582.79	376.05	349.06	289.82
Total Debt	2.79	2.6	0.41	0.81	0.22
Net Cash (Debt)	438.32	529.12	365.94	341.46	284.09
Net Cash Growth	-17.16%	44.59%	7.17%	20.19%	555.70%
Net Cash Per Share	4.25	5.67	4.59	5.22	7.69
Book Value	441.16	502.75	346.54	332.04	281.15
Book Value Per Share	4.27	5.39	4.34	5.07	7.61
Tangible Book Value	423.14	487.12	346.54	332.04	281.15
Tangible Book Value Per Share	4.10	5.22	4.34	5.07	7.61

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q